Principal Financial Group Inc. Increases Stock Holdings in Veeva Systems Inc. $VEEV

Key Points

• Principal Financial Group raised its stake in Veeva by 0.6%, buying 23,416 shares to hold 3,870,293 shares (about 2.35% of the company) valued at roughly $864 million.
• Veeva beat Q4 expectations with $2.06 EPS and $835.95M revenue (+16% YoY) and its board authorized a $2.0 billion stock buyback (up to 5.5% of outstanding shares).
• S&P 500 inclusion and GenAI tailwinds have fueled buying and a consensus "Moderate Buy" from analysts, with institutional investors owning 88.2% of shares while an insider sold 750 shares under a Rule 10b5‑1 plan.

Principal Financial Group Inc. raised its stake in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,870,293 shares of the technology company's stock after buying an additional 23,416 shares during the quarter. Principal Financial Group Inc. owned about 2.35% of Veeva Systems worth $863,978,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. FWG Holdings LLC lifted its position in Veeva Systems by 26.8% in the fourth quarter. FWG Holdings LLC now owns 2,733 shares of the technology company's stock valued at $557,000 after buying an additional 578 shares during the last quarter. Varma Mutual Pension Insurance Co acquired a new position in Veeva Systems in the fourth quarter valued at about $8,527,000. PKO Investment Management Joint Stock Co lifted its position in Veeva Systems by 28.6% in the fourth quarter. PKO Investment Management Joint Stock Co now owns 2,700 shares of the technology company's stock valued at $603,000 after buying an additional 600 shares during the last quarter. Benjamin Edwards Inc. lifted its position in Veeva Systems by 9.9% in the fourth quarter. Benjamin Edwards Inc. now owns 8,928 shares of the technology company's stock valued at $1,993,000 after buying an additional 803 shares during the last quarter. Finally, PFA Pension Forsikringsaktieselskab acquired a new position in Veeva Systems in the fourth quarter valued at about $10,602,000. Institutional investors and hedge funds own 88.20% of the company's stock.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: S&P 500 addition and GC transition: Veeva’s inclusion in the S&P 500 and reported general counsel transition triggered strong buying interest, a primary reason for today’s upside as index funds and ETFs track the addition. Read More.
• Positive Sentiment: GenAI tailwinds: Multiple industry write-ups single out Veeva as a beneficiary of accelerating GenAI adoption in healthcare — reinforcing the growth story and investor appetite for software companies exposed to AI-driven workflow demand. Read More.
• Positive Sentiment: Analyst consensus / “Moderate Buy”: Broker surveys and coverage summaries show a constructive analyst stance (consensus “Moderate Buy”), which supports momentum following the S&P news and can attract additional buy-side interest. Read More.
• Neutral Sentiment: Brokerage commentary / ABR pieces: Media stories noting that brokers suggest buying Veeva may amplify demand, but several caution that average broker ratings can be optimistic — useful for sentiment but not definitive fundamental change. Read More.
• Neutral Sentiment: Coverage repeat: Additional write-ups (Zacks / industry pieces) reiterate the GenAI angle and the firm’s positioning — supportive background but largely confirmatory rather than news-driving. Read More.
• Negative Sentiment: Insider sale disclosed: Director Priscilla Hung sold 750 shares under a Rule 10b5-1 plan; while pre-arranged plans are common, insider selling can prompt some investors to reassess near-term conviction. Read More.
• Neutral Sentiment: Price action write-ups: Market observers noted a gap-up and heightened volume following the S&P inclusion — validates the move but doesn’t add new fundamentals. Read More.

Veeva Systems Stock Down 0.7%

Shares of Veeva Systems stock opened at $170.47 on Tuesday. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50. The company has a 50 day moving average of $174.70 and a 200 day moving average of $216.26. The company has a market capitalization of $27.84 billion, a P/E ratio of 31.51, a P/E/G ratio of 0.77 and a beta of 0.92.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its quarterly earnings data on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating analysts' consensus estimates of $1.94 by $0.12. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The company had revenue of $835.95 million for the quarter, compared to the consensus estimate of $810.95 million. During the same period in the prior year, the firm posted $1.74 EPS. The company's quarterly revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, research analysts anticipate that Veeva Systems Inc. will post 6.41 earnings per share for the current fiscal year.

Veeva Systems announced that its Board of Directors has authorized a stock repurchase program on Monday, January 5th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the technology company to reacquire up to 5.5% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on VEEV shares. UBS Group upped their target price on shares of Veeva Systems from $200.00 to $220.00 and gave the company a "neutral" rating in a research report on Thursday, March 5th. The Goldman Sachs Group started coverage on shares of Veeva Systems in a research report on Tuesday, January 13th. They issued a "sell" rating and a $215.00 target price on the stock. Wells Fargo & Company decreased their target price on shares of Veeva Systems from $333.00 to $317.00 and set an "overweight" rating on the stock in a research report on Thursday, March 5th. Piper Sandler decreased their target price on shares of Veeva Systems from $355.00 to $285.00 and set an "overweight" rating on the stock in a research report on Thursday, March 5th. Finally, Morgan Stanley upped their target price on shares of Veeva Systems from $205.00 to $215.00 and gave the company an "equal weight" rating in a research report on Thursday, March 5th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Veeva Systems has a consensus rating of "Moderate Buy" and a consensus target price of $278.70.

Insider Activity at Veeva Systems

In related news, Director Priscilla Hung sold 750 shares of the business's stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares in the company, valued at approximately $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.30% of the company's stock.

Veeva Systems Company Profile

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.